PQ 698
698. Deputy John Brassil asked the Minister for Health the reason high-tech medicines for small patient populations are increasingly not recommended for reimbursement here despite their availability across the majority of European member states; and if he will make a statement on the matter. [13198/19]
Introduced
26 March 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
26 March 2019
Summary
698. Deputy John Brassil asked the Minister for Health the reason high-tech medicines for small patient populations are increasingly not recommended for reimbursement here despite their availability across the majority of European member states; and if he will make a statement on the matter. [13198/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 26 March 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-03-26/698/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-03-26/pq_698